Louis Greer, DPM
Primary Podiatric Medicine · Harrisburg, PANPI 1154380558
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 62.2% of it on its own, with 22 other manufacturers making up the rest.
Across 132 payments — averaging $25.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Stryker$361
- Cashflow Solutions, LLC$179
- Lifenet Health$116
- Pfizer$111
- Integra Lifesciences Corporation$60
- plus $453 from 17 others
What the payments were for
- Food & beverage$3,384100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 76 | $2,104 |
| Stryker | 9 | $361 |
| Cashflow Solutions, LLC | 6 | $179 |
| Lifenet Health | 3 | $116 |
| Pfizer | 12 | $111 |
| Integra Lifesciences Corporation | 3 | $60 |
| Polynovo North America LLC | 2 | $52 |
| Acera Surgical, Inc. | 2 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Nevro Corp. | 2 | $38 |
| Tactile Systems Technology Inc | 1 | $35 |
| Biocomposites Inc | 1 | $33 |
| AbbVie | 2 | $30 |
| Sebela Pharmaceuticals Inc. | 1 | $22 |
| Globus Medical | 1 | $22 |
| Amgen | 1 | $20 |
| KCI USA, Inc. | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $15 |
| Reddress USA, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| Paragon 28, Inc. | 1 | $13 |
| Axogen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$125
- Grafix$125
- STRAVIX PL$125
- GRAFIX PL$125
- Lympha Press Optimal Plus(US) BT$122
- PCD-51 731A (US) - White$122
- PCD-52 737A (US) White$122
How this compares
$3,384 in reported general payments places this provider in the 85th percentile of 31 primary podiatric medicine providers in Pennsylvania.
See all primary podiatric medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $16,578 |
| Pregabalin | 41 | $1,694 |
| Bumetanide | 83 | $1,455 |
| Duloxetine Hcl | 105 | $1,440 |
| Gentamicin Sulfate | 15 | $1,301 |
| Terbinafine Hcl | 57 | $647 |
| Allopurinol | 36 | $398 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $349 |
| Celecoxib | 17 | $309 |
| Ammonium Lactate | 20 | $301 |
| Ciprofloxacin Hcl | 16 | $255 |
| Oxycodone Hcl | 31 | $209 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $144 |
| Amitriptyline Hcl | 23 | $120 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $2,104 | $16,57811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 31 primary podiatric medicine providers in Pennsylvania.
Other primary podiatric medicine in Harrisburg
- Donald MrdjenovichAltoona$26K
- Michael DowneyPhiladelphia$9K
- Paul GoehringBeaver Falls$5K
- Carl MattiaYardley$4K
- Vincent PongiaCoatesville$3K
- Kenneth D'ortonePhiladelphia$2K
- Ketan KothariPhiladelphia$2K
- Gary CortesePottsville$1K
- Gerald GronborgMc Connellsburg$1K
- Kenneth LefkowitzDoylestown$967
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.